Macen J, Takahashi A, Moon K B, Nathaniel R, Turner P C, Moyer R W
Department of Molecular Genetics and Microbiology, College of Medicine, University of Florida, Gainesville 32610-0266, USA.
J Virol. 1998 May;72(5):3524-33. doi: 10.1128/JVI.72.5.3524-3533.1998.
The cowpox virus (CPV) CrmA and the equivalent rabbitpox virus (RPV) SPI-2 proteins have anti-inflammatory and antiapoptosis activity by virtue of their ability to inhibit caspases, including the interleukin-1beta-converting enzyme (ICE; caspase-1). Infection of LLC-PK1 pig kidney cells with a CPV CrmA mutant, but not with wild-type (wt) CPV, results in the induction of many of the morphological features of apoptosis (C. A. Ray and D. J. Pickup, Virology 217:384-391, 1996). In our study, LLC-PK1 cells infected with CPV delta crmA, but not those infected with wt CPV, showed induction of poly(ADP-ribose) polymerase (PARP)- and lamin A-cleaving activities and processing of the CPP32 (caspase-3) precursor to a mature 18-kDa form. Surprisingly, infection of LLC-PK1 cells with either wt RPV (despite the presence of the SPI-2 protein) or RPV delta SPI-2 resulted in cleavage activity against PARP and lamin A and the appearance of the mature subunit of CPP32/caspase-3. The biotinylated specific peptide inhibitor Ac-Tyr-Val-Lys(biotinyl)-Asp-2,6-dimethylbenzoyloxymethylketone [AcYV(bio)KD-aomk] labeled active caspase subunits of 18, 19, and 21 kDa in extracts from LLC-PK1 cells infected with CPV delta crmA, wt RPV, or RPV delta SPI-2 but not wt CPV. Mixed infection of LLC-PK1 cells with wt RPV and wt CPV gave no PARP-cleaving activity, and all PARP cleavage mediated by SPI-2 and CrmA mutants of RPV and CPV, respectively, could be eliminated by coinfection with wt CPV. These results suggest that the RPV SPI-2 and CPV CrmA proteins are not functionally equivalent and that CrmA, but not SPI-2 protein, can completely prevent apoptosis in LLC-PK1 cells under these conditions.
牛痘病毒(CPV)的CrmA蛋白和与之对应的兔痘病毒(RPV)的SPI-2蛋白具有抗炎和抗凋亡活性,因为它们能够抑制包括白细胞介素-1β转换酶(ICE;半胱天冬酶-1)在内的半胱天冬酶。用CPV CrmA突变体感染LLC-PK1猪肾细胞,而非野生型(wt)CPV,会导致许多凋亡的形态学特征出现(C. A. Ray和D. J. Pickup,《病毒学》217:384 - 391,1996)。在我们的研究中,感染CPV δ crmA的LLC-PK1细胞,而非感染wt CPV的细胞,显示出聚(ADP - 核糖)聚合酶(PARP)和核纤层蛋白A切割活性的诱导以及CPP32(半胱天冬酶-3)前体加工成成熟的18 kDa形式。令人惊讶的是,用wt RPV(尽管存在SPI-2蛋白)或RPV δ SPI-2感染LLC-PK1细胞均导致针对PARP和核纤层蛋白A的切割活性以及CPP32/半胱天冬酶-3成熟亚基的出现。生物素化的特异性肽抑制剂Ac-Tyr-Val-Lys(生物素基)-Asp-2,6-二甲基苯甲酰氧基甲基酮[AcYV(bio)KD-aomk]标记了感染CPV δ crmA、wt RPV或RPV δ SPI-2的LLC-PK1细胞提取物中18、19和21 kDa的活性半胱天冬酶亚基,但未标记wt CPV感染的细胞提取物中的活性亚基。用wt RPV和wt CPV混合感染LLC-PK1细胞未产生PARP切割活性,并且分别由RPV和CPV的SPI-2和CrmA突变体介导的所有PARP切割可通过与wt CPV共同感染而消除。这些结果表明,RPV的SPI-2蛋白和CPV的CrmA蛋白在功能上不等同,并且在这些条件下,CrmA而非SPI-2蛋白能够完全阻止LLC-PK1细胞凋亡。